Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 2
2018 6
2019 7
2020 3
2021 5
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression.
Reif A, Bitter I, Buyze J, Cebulla K, Frey R, Fu DJ, Ito T, Kambarov Y, Llorca PM, Oliveira-Maia AJ, Messer T, Mulhern-Haughey S, Rive B, von Holt C, Young AH, Godinov Y; ESCAPE-TRD Investigators. Reif A, et al. N Engl J Med. 2023 Oct 5;389(14):1298-1309. doi: 10.1056/NEJMoa2304145. N Engl J Med. 2023. PMID: 37792613 Clinical Trial.
Antipsychotic drugs in epilepsy.
Górska N, Słupski J, Cubała WJ. Górska N, et al. Neurol Neurochir Pol. 2019;53(6):408-412. doi: 10.5603/PJNNS.a2019.0052. Epub 2019 Nov 4. Neurol Neurochir Pol. 2019. PMID: 31681966
Antidepressants in epilepsy.
Górska N, Słupski J, Cubała WJ, Wiglusz MS, Gałuszko-Węgielnik M. Górska N, et al. Neurol Neurochir Pol. 2018 Nov-Dec;52(6):657-661. doi: 10.1016/j.pjnns.2018.07.005. Epub 2018 Aug 11. Neurol Neurochir Pol. 2018. PMID: 30131174 Review.
Efficacy of Ketamine in bipolar depression: focus on anhedonia.
Gałuszko-Węgielnik M, Wiglusz MS, Słupski J, Szałach Ł, Włodarczk A, Górska N, Szarmach J, Jakuszkowiak-Wojten K, Wilkowska A, Cubała WJ. Gałuszko-Węgielnik M, et al. Among authors: gorska n. Psychiatr Danub. 2019 Sep;31(Suppl 3):554-560. Psychiatr Danub. 2019. PMID: 31488790 Review.
Role of copper and ketamine in major depressive disorder - an update.
Słupski J, Słupska A, Szałach ŁP, Włodarczyk A, Górska N, Szarmach J, Jakuszkowiak-Wojten K, Gałuszko-Węgielnik M, Wilkowska A, Wiglusz MS, Cubała WJ. Słupski J, et al. Among authors: gorska n. Psychiatr Danub. 2019 Sep;31(Suppl 3):520-523. Psychiatr Danub. 2019. PMID: 31488784 Review.
Magnesium in Ketamine Administration in Treatment-Resistant Depression.
Górska N, Cubała WJ, Słupski J, Wiglusz MS, Gałuszko-Węgielnik M, Kawka M, Grzegorzewska A. Górska N, et al. Pharmaceuticals (Basel). 2021 May 3;14(5):430. doi: 10.3390/ph14050430. Pharmaceuticals (Basel). 2021. PMID: 34063604 Free PMC article.
Magnesium and ketamine in the treatment of depression.
Górska N, Słupski J, Szałach ŁP, Włodarczyk A, Szarmach J, Jakuszkowiak-Wojten K, Gałuszko-Węgielnik M, Wilkowska A, Wiglusz MS, Cubała WJ. Górska N, et al. Psychiatr Danub. 2019 Sep;31(Suppl 3):549-553. Psychiatr Danub. 2019. PMID: 31488789 Free article.
The immunomodulatory effect of ketamine in depression.
Szałach ŁP, Lisowska KA, Słupski J, Włodarczyk A, Górska N, Szarmach J, Jakuszkowiak-Wojten K, Gałuszko-Węgielnik M, Wiglusz MS, Wilkowska A, Cubała WJ. Szałach ŁP, et al. Among authors: gorska n. Psychiatr Danub. 2019 Sep;31(Suppl 3):252-257. Psychiatr Danub. 2019. PMID: 31488736
28 results